- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00583505
Emergency/Compassionate Use - Membranous VSD Occluder
February 1, 2019 updated by: Abbott Medical Devices
Emergency/Compassionate use of the AMPLATZER Membranous VSD Occluder
Study Overview
Status
No longer available
Conditions
Intervention / Treatment
Study Type
Expanded Access
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Emergency/compassionate use for patients not meeting the inclusion critera for the AMPLATZER Membranous VSD clinical trial
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Registration Dates
First Submitted
December 20, 2007
First Submitted That Met QC Criteria
December 28, 2007
First Posted (Estimate)
December 31, 2007
Study Record Updates
Last Update Posted (Actual)
February 4, 2019
Last Update Submitted That Met QC Criteria
February 1, 2019
Last Verified
February 1, 2019
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- AGA-008 E/C
- G020202
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Membranous
-
Hospital Universitario 12 de OctubreInstituto de Investigación Sanitaria de la Fundación Jiménez Díaz; Fundación... and other collaboratorsCompletedMEMBRANOUS NEPHROPATHYSpain
-
Beijing Friendship HospitalRecruitingIdiopathic Membranous NephropathyChina
-
Qianfoshan HospitalNot yet recruitingIdiopathic Membranous Nephropathy
-
Qianfoshan HospitalNot yet recruitingIdiopathic Membranous Nephropathy
-
Peking Union Medical College HospitalBeijing Tongren Hospital; Shanghai Fosun Pharmaceutical Industrial Development... and other collaboratorsRecruitingIdiopathic Membranous NephropathyChina
-
wanglinCompletedIdiopathic Membranous NephropathyChina
-
Manchester University NHS Foundation TrustFresenius AGCompletedAutoimmune Membranous NephropathyUnited Kingdom
-
Guangdong Provincial People's HospitalTerminatedIdiopathic Membranous NephropathyChina
-
Xinhua Hospital, Shanghai Jiao Tong University...UnknownIdiopathic Membranous NephropathyChina
-
National Institute of Diabetes and Digestive and...CompletedMembranous Glomerulonephritis | Lupus Membranous NepropathyUnited States
Clinical Trials on Device closure with the AMPLATZER Membranous VSD Occluder
-
Abbott Medical DevicesCompletedHeart Septal Defects, VentricularUnited States
-
Abbott Medical DevicesCompletedMembranous Ventricular Septal DefectsUnited States
-
Abbott Medical DevicesNo longer availablePatent | Ductus | Arteriosus
-
Abbott Medical DevicesApproved for marketingPatent Foramen Ovale | PFO
-
Abbott Medical DevicesActive, not recruitingVentricular Septal DefectsUnited States, Canada
-
Abbott Medical DevicesCompletedPatent Ductus Arteriosus (PDA)United States
-
Shanghai Zhongshan HospitalRecruiting
-
Abbott Medical DevicesRecruiting
-
SeptRx, Inc.UnknownHeart Septal Defects | Heart Defects, Congenital | Foramen Ovale, PatentGermany, France